The Mumbai-based pharmaceutical firm IPCA Laboratories Ltd today reported a net profit of Rs 76.61 crore for the fourth quarter ended March 31, 2012 as against a net profit of Rs 58.57 crore in the year ago period, the company said in a regulatory filing to the BSE. The net sales stood at Rs 553.11 crore in the quarter under review versus Rs 473.78 crore in the same period of previous fiscal.
The financial figures of the current quarter and fiscal are not comparable with those of the previous financial year due to amalgamation of Tonira Pharma with the company with effect from April 1, 2011. For the year ended Mach 31, 2012 IPCA reported a net profit of Rs 280.17 crore as compared to Rs 255.37 crore during 2010-11.
IPCA's Board, which met today, recommended a final dividend of Rs 1.20 per share of Rs 2 each (60 percent) for the financial year 2011-12. Shares of Ipca Laboratories rallied at Rs 325.70 on the BSE in late afternoon trade, down 2.76 percent from its previous close.
